Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Matt E Kalaycio"'
Autor:
Caner Saygin, Ashwin Kishtagari, Ryan D. Cassaday, Natalie Reizine, Ilana Yurkiewicz, Michaela Liedtke, Wendy Stock, Richard A. Larson, Ross L. Levine, Martin S. Tallman, Jae H. Park, Cassandra Kerr, Bartlomiej Przychodzen, Mikkael A. Sekeres, Matt E. Kalaycio, Hetty E. Carraway, Betty K. Hamilton, Ronald Sobecks, Aaron Gerds, Sudipto Mukherjee, Aziz Nazha, Jaroslaw P. Maciejewski, Anjali S. Advani
Publikováno v:
Blood Advances, Vol 3, Iss 24, Pp 4228-4237 (2019)
Abstract: Patients with therapy-related acute lymphoblastic leukemia (t-ALL) represent a small subset of acute lymphoblastic leukemia (ALL) patients who received genotoxic therapy (ie, chemotherapy or radiation) for a prior malignancy. These patients
Externí odkaz:
https://doaj.org/article/cab86d84cd7c4e9c8f87db118e5bdbb6
Autor:
Betty K. Hamilton, Lisa A. Rybicki, David Grove, Christina Ferraro, Jamie Starn, Brittany Hodgeman, Jamie Elberson, Victoria Winslow, Donna Corrigan, Aaron T. Gerds, Rabi Hanna, Matt E. Kalaycio, Ronald M. Sobecks, Navneet S. Majhail, Raed A. Dweik
Publikováno v:
Blood Advances, Vol 3, Iss 18, Pp 2732-2737 (2019)
Volatile organic compounds (VOCs) are generated during pathologic processes, and their assessment can be used to diagnose and monitor a variety of diseases. Given the role of the microbiome in graft-versus-host disease (GVHD), we hypothesized that mi
Externí odkaz:
https://doaj.org/article/794c4d6568cd4ea8a11009c9d8ca0937
Autor:
Suhani Mehta, Danielle A. Cenin, Seema Patel, Chi-Fan Hockings, Claudio G. Brunstein, Matt E. Kalaycio, Craig S Sauter, Ronald M. Sobecks, Betty K. Hamilton
Publikováno v:
Transplantation and Cellular Therapy. 29:S175-S176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854c6e5a2bf01be3f81523df5348af11
https://doi.org/10.1016/s2666-6367(23)00295-6
https://doi.org/10.1016/s2666-6367(23)00295-6
Autor:
Kelly J Gaffney, Theresa A Urban, Mariana Lucena, Faiz Anwer, Robert M Dean, Aaron T Gerds, Betty K Hamilton, Deepa Jagadeesh, Matt E Kalaycio, Jack Khouri, Brad Pohlman, Ronald Sobecks, Allison Winter, Lisa Rybicki, Navneet S Majhail, Brian T Hill
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Busulfan-based conditioning regimens are associated with serious toxicities and literature reports increased risk of toxicities when daily area under the curve concentrations exceed 6000 µM-minute. We implemented real time pharmacokinetic-guided the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3dc6d4c9351ef0006a21f0fb67ce62
https://pubmed.ncbi.nlm.nih.gov/35673764
https://pubmed.ncbi.nlm.nih.gov/35673764
Autor:
Nikki Agarwal, Pranay Hegde, Li Hong, Claudio G. Brunstein, Rabi Hanna, Matt E. Kalaycio, Seth J Rotz, Ronald M. Sobecks, Craig S Sauter, Betty K. Hamilton
Publikováno v:
Transplantation and Cellular Therapy. 29:S362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9a2f902e9b4672fbc72180b761c52b1
https://doi.org/10.1016/s2666-6367(23)00550-x
https://doi.org/10.1016/s2666-6367(23)00550-x
Autor:
Lauren M Granat, Lisa Rybicki, Mailey L Wilks, Christina S Ferraro, Matt E. Kalaycio, Ronald M. Sobecks, Navneet S. Majhail, Dana M Angelini, Betty K. Hamilton
Publikováno v:
Transplantation and Cellular Therapy. 28:S116-S117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b2d767b7675cdbc62da56b485b6dfdf
https://doi.org/10.1016/s2666-6367(22)00304-9
https://doi.org/10.1016/s2666-6367(22)00304-9
Autor:
Agrima Mian, Wei Wei, Allison M. Winter, Jack Khouri, Deepa Jagadeesh, Faiz Anwer, Aaron T. Gerds, Robert M. Dean, Ronald M. Sobecks, Brad Pohlman, Matt E. Kalaycio, Betty K. Hamilton, Paolo F. Caimi, Brian T. Hill
Publikováno v:
Transplantation and Cellular Therapy. 28:S146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4da3d5d4ce5189c6be7ef0a76fa359c
https://doi.org/10.1016/s2666-6367(22)00337-2
https://doi.org/10.1016/s2666-6367(22)00337-2
Autor:
Avudaiappan Maran, Cornelius F. Waller, Jayashree M. Paranjape, Guiying Li, Wei Xiao, Kerry Zhang, Matt E. Kalaycio, Ratan K. Maitra, Alan E. Lichtin, Wolfram Brugger, Paul F. Torrence, Robert H. Silverman
Publikováno v:
Blood. 92:4336-4343
We report an RNA targeting strategy, which selectively degrades bcr/abl mRNA in chronic myelogenous leukemia (CML) cells. A 2′,5′-tetraadenylate activator (2-5A) of RNase L was chemically linked to oligonucleotide antisense directed against eithe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c14232314b31aecf987d4caa1f745023
https://doi.org/10.1182/blood.v92.11.4336.423a06_4336_4343
https://doi.org/10.1182/blood.v92.11.4336.423a06_4336_4343
Autor:
Stephen D. Smith, Brian J. Bolwell, Anjali S. Advani, Steven W. Andresen, Josephine L. Chan, Robert M. Dean, Eric D. Hsi, Matt E. Kalaycio, Brad L. Pohlman, Lisa A. Rybicki, John W. Sweetenham
Publikováno v:
Leukemialymphoma. 50(10)
Transformed lymphoma (TL) is historically associated with a poor prognosis, though autologous stem cell transplantation (ASCT) has been applied successfully. Better patient selection is needed for this intensive therapy. We analyzed the outcomes betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65251d14bf562de4aedb3784e5f0a2e6
https://pubmed.ncbi.nlm.nih.gov/19672775
https://pubmed.ncbi.nlm.nih.gov/19672775
Autor:
Mark A. Weiss, Joseph G. Jurcic, Martin S. Tallman, E B S Todd Roma, Stanley R. Frankel, Timothy B. Aliff, Matt E. Kalaycio, Peter G. Maslak, David A. Scheinberg
Publikováno v:
Cancer. 95(3)
BACKGROUND The majority of adult patients who are treated for lymphoblastic disease will either develop recurrent disease or will be refractory to their initial therapy. One option for patients with recurrent/refractory disease is to administer a rei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5fae8442b4d39c532ad32c1f4ad01c
https://pubmed.ncbi.nlm.nih.gov/12209751
https://pubmed.ncbi.nlm.nih.gov/12209751